HB Investment

HB Investment Inc. is a Korean venture capital firm established on November 11, 1999, with an initial paid-in capital of KRW 10 billion. Based in Seoul, the company focuses on investing in small and medium-sized enterprises that demonstrate potential for steady growth and profitability. In addition to financial investment, HB Investment provides various consulting services to support the development of its portfolio companies. Over the years, the firm has built a diverse portfolio across multiple sectors, including gaming, entertainment, high-tech industries such as semiconductors and LCDs, as well as biotechnology and healthcare. HB Investment has also gained experience in successfully managing several partnership funds, further enhancing its capabilities in fostering business success.

Park Ha-jin

CEO

Past deals in South Korea

MakinaRocks

Funding Round in 2024
MakinaRocks is a global AI software startup based in Seoul, South Korea, founded in 2017. The company specializes in developing an enterprise artificial intelligence platform that addresses industry-specific challenges through machine intelligence. Its offerings include MLOps for the development and operation of AI models, as well as solutions for anomaly detection and operational optimization, aimed at enhancing industrial productivity. By integrating industry-specific AI model development capabilities, MakinaRocks provides businesses with efficient and cost-effective pathways for automation, predictive maintenance, and quality control, ultimately elevating operational efficiency across various sectors.

Onheal

Series B in 2023
Onheal is a company based in South Korea that specializes in the veterinary field, focusing on the development and distribution of medicines and medical devices for companion animals. The company operates a healthcare platform aimed at extending the lives of pets by providing essential animal medicines and equipment. Through rigorous veterinary research and efficacy testing, Onheal offers products that promote the health and well-being of companion animals, ensuring pet owners have access to high-quality functional food and necessary items for their pets' care.

EnhancedBio

Series C in 2022
EnhancedBio Inc. is a biopharmaceutical company based in Seoul, South Korea, focused on researching and developing anti-cancer therapeutics. The company has a pipeline that includes HPV siRNA therapeutics aimed at treating various cancers associated with Human Papilloma Virus (HPV) infections. In addition to HPV-targeted treatments, EnhancedBio is also developing small molecular drugs targeting other oncological pathways, such as PTEN, PMVK, and RRM2. By concentrating on target-specific drugs and companion diagnostics, EnhancedBio aims to enhance cancer treatment options available to healthcare professionals and improve outcomes for patients worldwide. The company was incorporated in 2016.

Bbodek

Series B in 2022
Bbodek is a company based in Seoul, South Korea, specializing in tableware rental and washing services primarily for restaurants and school cafeterias. The company offers a range of products, including children's tableware, and emphasizes hygiene management. Bbodek leverages its self-developed smart factory technology to ensure low-defect services, allowing clients to concentrate on cooking without the burden of cleanup. Additionally, Bbodek is expanding its operations to include the manufacture and sale of customized washing machines, further enhancing its service offerings in the food service industry.

MakinaRocks

Series A in 2020
MakinaRocks is a global AI software startup based in Seoul, South Korea, founded in 2017. The company specializes in developing an enterprise artificial intelligence platform that addresses industry-specific challenges through machine intelligence. Its offerings include MLOps for the development and operation of AI models, as well as solutions for anomaly detection and operational optimization, aimed at enhancing industrial productivity. By integrating industry-specific AI model development capabilities, MakinaRocks provides businesses with efficient and cost-effective pathways for automation, predictive maintenance, and quality control, ultimately elevating operational efficiency across various sectors.

Odd Concepts

Series B in 2020
Odd Concepts Inc. is a technology company specializing in computer vision and artificial intelligence solutions. Founded in 2012 and based in Seoul, South Korea, it offers a comprehensive portfolio of image recognition and search technologies delivered as a cloud-based API service. The company's innovative platform is designed to meet diverse customer needs by allowing for the tuning and combination of analysis engines to achieve optimal results. Additionally, Odd Concepts develops software for video content searches, facilitating connections between offline retail businesses and online markets. This enables clients to conduct product data analysis and provide personalized product recommendations, enhancing the overall shopping experience.

Laseroptek

Venture Round in 2020
Laseroptek Co. Ltd. is a South Korean company founded in 2000, specializing in the development and manufacturing of laser equipment for medical and industrial applications. The company offers a range of products designed for various skin treatments, including the picolo, which targets pigmented lesions, tattoos, scars, and skin rejuvenation; the pallas, an ultraviolet laser system for complex skin conditions like vitiligo and psoriasis; and the zelos, an alexandrite laser system. Additionally, Laseroptek produces the helios and lotus series, as well as the hyperion, a long pulsed laser system known for its stability and effectiveness. The company serves a global market, providing advanced solutions for tattoo removal, pigmentation correction, laser toning, and skin rejuvenation.

Dabeeo

Series A in 2019
Dabeeo Inc., founded in 2012 and based in Seoul, South Korea, is an AI technology company that specializes in geospatial data. The company has developed a mapping technology platform that utilizes artificial intelligence and deep learning to manage and enhance spatial data. By digitizing the Earth's spatial information, Dabeeo creates a digital twin of the planet, providing businesses with essential digital spatial analysis data and insights. This innovative approach allows users to access live maps and locations, perform open-source map editing, and obtain high-quality map data, thereby improving productivity and convenience across various industries.

HonestFund

Series B in 2019
HonestFund Co., LTD. is a financial technology company based in Seoul, South Korea, founded in 2015. It operates an online financial platform that provides access to a diverse array of investment opportunities, including residential and commercial real estate, infrastructure financing, unsecured personal loans, and various bond investment products. The platform is designed to facilitate a transparent and efficient process for both investors and private issuers, thereby attracting significant investments from prominent financial institutions. HonestFund's unique offering allows individuals and institutional investors to engage in alternative investments, enhancing their portfolio diversification and access to capital.

Crowdworks

Series B in 2019
CrowdWorks, Inc. is a South Korea-based company that operates an online crowdsourcing platform specifically designed for artificial intelligence (AI). The company focuses on enhancing machine learning processes by collecting, structuring, and strengthening training data. It provides services that include the analysis and classification of various types of data, such as images, text, audio, and survey responses. By utilizing a pool of approximately 500,000 qualified labelers, CrowdWorks aims to improve the accuracy of human-powered data, thereby streamlining the AI model training workflow. The platform's Auto-ML features facilitate efficient data preparation, making it an essential resource for over 430 leading AI companies seeking to rapidly develop and deploy advanced AI solutions.

HonestFund

Series B in 2018
HonestFund Co., LTD. is a financial technology company based in Seoul, South Korea, founded in 2015. It operates an online financial platform that provides access to a diverse array of investment opportunities, including residential and commercial real estate, infrastructure financing, unsecured personal loans, and various bond investment products. The platform is designed to facilitate a transparent and efficient process for both investors and private issuers, thereby attracting significant investments from prominent financial institutions. HonestFund's unique offering allows individuals and institutional investors to engage in alternative investments, enhancing their portfolio diversification and access to capital.

Vuno

Series B in 2018
Vuno Inc. is a South Korean company specializing in the development of artificial intelligence solutions for the medical field. Founded in 2014, Vuno focuses on creating AI-based products that assist healthcare professionals in analyzing medical data and diagnosing diseases. Its notable offerings include BoneAge, which assesses bone age, DeepBrain, designed for the analysis of neurodegenerative diseases, and a chest X-ray diagnostic support system. Additionally, Vuno provides fundus AI for eye abnormalities and LungCT AI for detecting and reporting pulmonary nodules. The company serves a range of clients, including Asan Medical Center and HYUNDAI, and also offers VunoMed, a platform for analyzing various medical data types, including videos, ECGs, and electronic medical records.

Birdview

Series B in 2018
BirdView Inc. is a South Korean company that specializes in developing and providing an internet-based mobile application focused on cosmetics reviews and information. Its primary product is HwaHae, an application available on both iOS and Android platforms. HwaHae enables users to access detailed information about the components of various cosmetic products, facilitating informed decision-making for consumers interested in beauty products.

DeepSearch

Series B in 2018
DeepSearch, Inc. operates a financial research platform designed for individual investors, delivering a range of tools and solutions for financial analysis. The company's primary offerings include DeepSearch, an online platform that provides comprehensive financial information and analysis, and SNEK, which assists users in evaluating companies. Additionally, the firm offers DDI Alerts, a service that helps users mitigate risks and make informed decisions quickly, and Index, a feature that allows users to create customized indices. Founded in 2013 and based in Seoul, South Korea, DeepSearch aims to empower individuals with the data and analytics needed to navigate the financial landscape effectively.

DxGen

Venture Round in 2018
DxGen Corp. is a diagnostics company focused on developing tools for diabetes care. Established in 2016 and headquartered in Gunpo-si, South Korea, with a sales office in San Diego, California, DxGen offers a range of products designed for point-of-care testing. Its portfolio includes the Epithod616 semi-automatic analyzer, the fully-automatic Epithod AutoDx, a magnetic particle separator named MagSep, and an immune-assay analyzer. These tools facilitate the entire diabetes care process, from initial assessment through post-diagnosis treatment, enabling healthcare professionals to make timely clinical decisions regarding patient care. Additionally, DxGen aims to expand its offerings to include multi-marker diagnostics for conditions such as tuberculosis.

EnhancedBio

Venture Round in 2018
EnhancedBio Inc. is a biopharmaceutical company based in Seoul, South Korea, focused on researching and developing anti-cancer therapeutics. The company has a pipeline that includes HPV siRNA therapeutics aimed at treating various cancers associated with Human Papilloma Virus (HPV) infections. In addition to HPV-targeted treatments, EnhancedBio is also developing small molecular drugs targeting other oncological pathways, such as PTEN, PMVK, and RRM2. By concentrating on target-specific drugs and companion diagnostics, EnhancedBio aims to enhance cancer treatment options available to healthcare professionals and improve outcomes for patients worldwide. The company was incorporated in 2016.

Wellmarker Bio

Venture Round in 2018
Wellmarker Bio is engaged in the development of innovative cancer therapies, focusing on biomarker-based drugs tailored to address unmet medical needs in various cancers, including colon, lung, and liver cancer. The company leverages its extensive research expertise and a dedicated drug development institute, which encompasses departments for target discovery, drug discovery, medicinal chemistry, and CMC. By utilizing R&D infrastructure from Asan Medical Center in Seoul, South Korea, Wellmarker Bio aims to create first-in-class drugs that can effectively overcome resistance to existing treatments. The company's approach highlights its commitment to advancing cancer care and improving patient outcomes through targeted therapeutic innovations.

3D Medivision

Series B in 2018
3D MediVision, Inc. specializes in developing and manufacturing 3D visualization and live-casting systems specifically designed for surgical applications. Established in 2011 and based in Seoul, South Korea, the company offers a range of products including 3D/2D cameras, recorders, monitors, and ultrasound systems. Its technology enables surgeons to capture and display surgical procedures in high-definition 3D images, which can be streamed or recorded for educational purposes. Additionally, 3D MediVision provides SURGFLIX, a surgical content sharing platform for professionals, and VeterFlix, tailored for veterinary training. The company's products are distributed through authorized partners in various countries, including India, Spain, Mexico, and China, facilitating enhanced collaboration and knowledge sharing among surgical teams.

Parking Cloud

Series B in 2017
Parking Cloud Co., Ltd. is an online platform based in Seoul, South Korea, that provides a comprehensive solution for parking management. Founded in 2009, the company allows customers to check real-time parking availability, compare prices, and make payments through a mobile wallet. Its services extend beyond standard parking, incorporating features such as car sharing, car rental, maintenance, car washing, and electric vehicle charging stations. Parking Cloud also engages in the development, leasing, and operation of parking facilities, including rentals for buses and freight vehicles. The company manufactures parking system devices that facilitate unmanned settlement processes in parking lots. By integrating these services, Parking Cloud aims to streamline the parking experience for users and enhance the management of parking spaces in urban areas.

Xcell Therapeutics

Venture Round in 2017
Xcell Therapeutics Inc. is a company focused on the development and production of drugs for cell therapy. Founded in 2015 and based in Seoul, South Korea, the company specializes in serum-free chemically defined media, with its key product being CellCor. This proprietary medium is utilized for the development of human mesenchymal stem cells, which play a crucial role in various therapeutic applications.

Vuno

Series A in 2016
Vuno Inc. is a South Korean company specializing in the development of artificial intelligence solutions for the medical field. Founded in 2014, Vuno focuses on creating AI-based products that assist healthcare professionals in analyzing medical data and diagnosing diseases. Its notable offerings include BoneAge, which assesses bone age, DeepBrain, designed for the analysis of neurodegenerative diseases, and a chest X-ray diagnostic support system. Additionally, Vuno provides fundus AI for eye abnormalities and LungCT AI for detecting and reporting pulmonary nodules. The company serves a range of clients, including Asan Medical Center and HYUNDAI, and also offers VunoMed, a platform for analyzing various medical data types, including videos, ECGs, and electronic medical records.

Doosan Fuel Cell

Venture Round in 2016
Doosan Fuel Cell Co., Ltd. is a South Korean company that specializes in the development and distribution of power generation fuel cells. Founded in 2019 and headquartered in Iksan-si, the company primarily focuses on its M400 fuel cell, which generates approximately 440 kW of power and heat. These fuel cells are utilized in various applications, including power plants, refrigerated warehouses, large buildings, and hot springs, as well as in projects involving natural gas, LPG, and hydrogen. The company is recognized for producing stable and efficient clean energy solutions.

Chinada

Series A in 2014
Chinada is an education company focused on learning in Chinese. The company’s operations are based in Seoul, Korea.

SolGent

Venture Round in 2014
SolGent Inc., founded in 2000 and based in Daejeon, South Korea, specializes in the development and manufacturing of molecular diagnostic kits and medical raw materials for genetic assays. The company provides a range of products, including DNA sequencing tools, DNA polymerase, and various reagents. SolGent's diagnostic kits are designed to assess the risk of infection through genetic information, enabling the detection of a variety of infectious diseases, such as sexually transmitted infections, tuberculosis, and influenza. Notably, the company utilizes highly stable versions of Taq polymerase that retain their effectiveness even after multiple freeze-thaw cycles, ensuring reliability in diagnostic applications.

Healcerion

Venture Round in 2013
Healcerion Co., Ltd. designs and develops mobile based healthcare systems to provide physicians and patients with point of care diagnostic information. The company was founded in 2012 and is based in Seoul, South Korea.

L&C BIO Company

Venture Round in 2013
L&C BIO Co., Ltd. is a research and development company specializing in tissue regeneration medicine, headquartered in Seongnam, South Korea. Founded in 2011, the company focuses on improving human health and quality of life through innovative products. L&C BIO develops and provides human tissue, medical devices, and cosmetics, aiming to meet customer needs while maintaining a commitment to quality and service. The company's philosophy emphasizes respect for customers and the delivery of valuable solutions in the healthcare sector.

Tripath

Venture Round in 2013
Tripath, founded in 2011 and based in Seoul, South Korea, specializes in designing and developing web, mobile, server, and application software. The company offers a live chat-based online sales platform aimed at enhancing corporate business processes. Its services include a one-stop environment that incorporates co-browsing, highlighting functions, and a sales closing module, enabling online consultations where clients and counselors can view the same screen. This approach facilitates customer engagement and aims to increase sales volumes for businesses. Additionally, Tripath provides an avenue for online counselors to market and sell their goods and services, further supporting revenue generation for its clients.

Aptamer Sciences

Venture Round in 2013
Aptamer Sciences, Inc. is a research and development-focused bio venture company based in Seongnam, South Korea, founded in 2011. The company specializes in the Aptamer technology platform, which enables the development of innovative therapeutics and diagnostic solutions. Aptamer Sciences is engaged in the discovery and optimization of high-performance aptamers, which are nucleic acid molecules that can bind to specific targets. Their product offerings include therapeutic platforms such as AlloMAp and BiFAp, as well as diagnostic kits for lung and pancreatic cancer, aimed at facilitating early diagnosis. By leveraging their expertise in aptamer technology, the company seeks to create advanced therapeutic agents and multi-index diagnostic tools that surpass the capabilities of traditional protein and genome-based materials.

Panax Etec

Venture Round in 2013
PANAX ETEC is a producer of electrolytes and additives based in Busan, South Korea. The company specializes in the development of electrolytes that support the functionality of portable electronic devices, particularly in the information technology and electric vehicle sectors. Its products are primarily used in lithium-ion batteries, which power devices such as cellphones and laptops. By providing essential components for battery lines, PANAX ETEC plays a crucial role in enhancing the performance and reliability of modern electronic technologies.

BioLeaders

Venture Round in 2012
BioLeaders Corporation is a healthcare company based in Yongin, South Korea, founded in 1999. The company focuses on developing innovative medicines, particularly in the field of oncology, with its flagship product being P53, an anti-cancer drug. BioLeaders is advancing several pipeline products, including BLS-H01, currently in phase 3 clinical trials for cervical cancer, and BLS-M07, which has completed phase 2b trials for the same condition. Additionally, the company is working on BLS-M22 for the treatment of Duchenne muscular dystrophy and BLC-H03, a vaccine adjuvant. Beyond pharmaceuticals, BioLeaders also offers health functional foods, raw materials, and functional cosmetic ingredients, positioning itself as a comprehensive provider in the healthcare sector.

AptaBio Therapeutics

Venture Round in 2011
AptaBio Therapeutics Inc. is a pharmaceutical biotechnology company based in Yongin-Si, South Korea, that specializes in the discovery and development of selective inhibitors targeting the NOX family of enzymes, as well as aptamer-based anti-cancer drugs. The company's product offerings include a range of transfection reagents designed for DNA or RNA delivery into eukaryotic cells. AptaBio is advancing several product candidates aimed at addressing significant health issues, including PX-115 for diabetic nephropathy, APX-1004 for diabetic retinopathy, and APX-311 for non-alcoholic steatohepatitis (NASH). Founded in 2009, AptaBio Therapeutics focuses on creating innovative solutions for complex medical challenges.

P&H TECH

Venture Round in 2011
P&H Tech Co., Ltd. is a South Korean company specializing in the development, production, and sale of organic light emitting diode (OLED) materials and catalysts. Founded in 2009 and headquartered in Yongin, the company offers a range of products, including general OLED materials, electron transport layers (EBL), hole transport layers (HTL), host materials, OLED intermediates, and various catalysts. P&H Tech primarily serves the OLED display market, leveraging its expertise in organic synthesis technology to produce high-quality chemical materials essential for semiconductor manufacturing.

Krafton

Venture Round in 2009
Krafton Inc is a South Korean video game developer and holding company headquartered in Seongnam. It specializes in creating fantasy games for both PC and mobile platforms, and it is renowned for its popular title, PlayerUnknown's Battlegrounds. In addition to this flagship game, Krafton has developed several other titles, including PUBG: Battlegrounds, PUBG: New State, Tera, Elyon, and Mistover. The company aims to maintain its status as a leading name in the video game industry by adhering to its core value of craftsmanship in game development.

Micro Digital

Venture Round in 2008
Micro Digital is a South Korea-based biotechnology company that specializes in providing systems for the biomedical and environmental industries. Its product offerings include a Fully Automatic Immuno Analyzer, Integrated Sample Banking Solution, Microplate Luminometer, Nano Spectrophotometer, and a Biomass Desiccation and Pulverization System. The company focuses on developing innovative solutions that cater to the needs of research and development in the biomedical sector.

The VIN CSR

Venture Round in 2006
The VIN CSR is a boutique wine company focused on introducing international wines to the South Korean market. The company is involved in importing, manufacturing, retailing, and wholesaling a diverse selection of wines, making varieties that are not easily accessible locally available to customers. Through its operations, The VIN CSR aims to enhance the wine selection in South Korea, providing consumers with unique options from around the world.

Anapass

Venture Round in 2004
AnaPass Inc. is a fabless semiconductor company based in Seoul, South Korea, specializing in the design and production of integrated circuit (IC) products for the global display panel market. The company offers solutions for both flat panel displays and mobile devices, utilizing high-speed serial link technologies. Its flat panel display solutions include Timing Controllers, which process video signals and transmit control signals to drive LCD panels. For mobile applications, AnaPass provides Mobile Serial Links that enhance efficiency by reducing power consumption and electromagnetic interference, alongside Mobile Display Controllers that handle complex data signals for mobile displays. Founded in 2002 and originally known as Anachips, Inc., the company rebranded to AnaPass Inc. in March 2004.

ICTK Co.

Venture Round in 2003
ICTK Co., Ltd., founded in 2001 and headquartered in Seongnam-si, South Korea, specializes in payment testing and certification services for mobile devices, payment cards, and point of sale terminals. The company is an accredited international testing laboratory for several industry standards, including EMVCo, Visa, JCB, Discover, Global Platform, and the NFC Forum. ICTK offers high-quality engineering services for smart cards, mobile devices, and terminals. Additionally, its Security R&D Division has developed a range of PUF (Physical Unclonable Functions)-based security chips and solutions, holding over 80 patents and licenses since 2006. ICTK is poised to launch innovative PUF-based solutions in collaboration with a prominent automobile group. As of December 2017, ICTK operates as a subsidiary of Bureau Veritas SA.

Payletter

Venture Round in 2003
Payletter Inc. is a company that specializes in online billing and payment services, serving clients across North America, Europe, and Asia. Founded in 2001 and headquartered in Seoul, South Korea, Payletter offers solutions like BillOneQ, which tracks digital content usage, including fixed amounts, time of use, and recurring charges, catering specifically to gaming, PC rooms, and digital products. Additionally, the company provides payoneQ, an integrated payment agent service designed to facilitate secure transactions. Payletter's platform is equipped with advanced security features, such as SSL support and AES encryption, ensuring efficient and secure payment solutions for its users, particularly in the gaming and digital content sectors.

Avixgen

Venture Round in 2002
Avixgen, Inc. is a South Korea-based company established in 2000 that specializes in the development of drugs, therapeutics, and diagnostics for infectious viral diseases. The company's research primarily focuses on formulating therapies for human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS). By advancing drug delivery technologies, Avixgen aims to enhance treatment options for these serious health conditions, thereby improving overall human health and providing healthcare providers with innovative therapeutic solutions.

Adbiotech

Venture Round in 2002
ADBiotech Co., Ltd. is a life science company based in Chuncheon-si, South Korea, specializing in the research and development of bio-products for human healthcare, livestock farming, and aquaculture. Founded in 2000, ADBiotech utilizes Immunoglobulin Y (IgY) technology to create orally administered antibodies that serve as alternatives to traditional vaccines and antibiotics. The company also develops functional cosmetics and natural food additives, focusing on health and wellness. Its product offerings include antibiotics, metabolic drugs, anthelmintics, disinfectants, and various feed supplements for livestock. Additionally, ADBiotech is involved in developing specific IgY products aimed at addressing health issues such as cholesterol management and ulcerative colitis. The company collaborates with academic institutions to enhance food safety and expand its product range through innovative research initiatives.

EyeGene

Venture Round in 2002
EyeGene Inc. is a biotechnology company based in Seoul, South Korea, focused on the research and development of biopharmaceutical drugs aimed at treating and preventing age-related diseases. Established in 2000, the company is actively advancing several product candidates through various stages of clinical trials. Its pipeline includes EG-Mirotin, which is in Phase IIa trials for diabetic retinopathy, and EG-HPV, which has completed Phase I trials for cervical cancer. Other notable products include EG-Decorin for pressure ulcers, EG-Myocin for heart muscle treatment, EG-TB for tuberculosis, and EG-HZ, currently in preclinical trials for herpes zoster. EyeGene's commitment to addressing degenerative diseases underscores its role in the biopharmaceutical sector.

SoundGraph

Venture Round in 2002
SoundGraph, Inc. is a multimedia company that specializes in digital media technology, providing a variety of products and services related to audio and video. Its offerings include FingerUI, a touch interface for playing various media formats, along with widgets such as weather updates and RSS feeds. The company also develops SmartPhone products like speaker docks for iPhones and iPads, home theater PCs, USB touch monitors, and other accessories. SoundGraph focuses on delivering innovative digital signage solutions, enabling businesses and retail stores to effectively manage and distribute multimedia content. Founded in 2000 and headquartered in Seoul, South Korea, SoundGraph markets its products online and through distributors across Asia, North America, and Europe.

Mobiis

Venture Round in 2002
Mobiis Co., Ltd. is a South Korean company based in Seongnam that specializes in designing and building equipment and systems for monitoring and controlling particle accelerator beams and related technologies. Founded in 2000, Mobiis offers a range of products, including control systems and equipment such as low-level radio frequency amplifiers, solid-state amplifiers, undulator controllers, and step motor controllers. The company also develops control systems for nuclear fusion reactors, incorporating services like control data access, communication frameworks, central interlock systems, and coil power supply systems. Additionally, Mobiis is involved in computer programming, system integration, and engineering services, providing intelligent control solutions across various sectors.

HIMS

Venture Round in 2001
HIMS Co., Ltd. is a South Korean manufacturer specializing in semiconductor solutions and factory automation products. Founded in 1999 and based in Incheon, the company develops and sells a range of inspection systems, including mask stretchers, mask repair products, and various inspection devices for the display and semiconductor fields. HIMS also offers vision modules and components such as light control boards, CCD and CMOS cameras, and other essential parts for machine operation. In addition to its hardware offerings, the company provides software solutions to enhance the functionality of its inspection systems.

Kukdong

Venture Round in 2001
Kukdong Corporation, founded in 1967 and based in Seoul, South Korea, specializes in the manufacture and sale of a diverse range of knit garments for men, women, and children. The company produces workwear, activewear—including training, golf, and fitness apparel—loungewear that encompasses home, room, sleep, and night garments, as well as various fashion wear. Kukdong is recognized for its use of functional materials in special workwear clothing designed for waterproofing and dustproofing. As an original equipment manufacturer, Kukdong supplies its products to prominent global retailers, including Nike, H&M, Columbia Sportswear, Target, and Walmart. In addition to its domestic operations, the company exports its offerings to markets in the United States, the European Union, and Chile.

DiNonA

Venture Round in 2001
DiNonA is a biotechnology company headquartered in Seoul, South Korea. It focuses on the research and development of therapeutic antibodies and diagnostic reagents related to antibodies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.